Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;28(2):626-640.
doi: 10.1177/0962280217734584. Epub 2017 Nov 9.

Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect

Affiliations

Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect

Moonseong Heo et al. Stat Methods Med Res. 2019 Feb.

Abstract

Comparative effectiveness research trials in real-world settings may require participants to choose between preferred intervention options. A randomized clinical trial with parallel experimental and control arms is straightforward and regarded as a gold standard design, but by design it forces and anticipates the participants to comply with a randomly assigned intervention regardless of their preference. Therefore, the randomized clinical trial may impose impractical limitations when planning comparative effectiveness research trials. To accommodate participants' preference if they are expressed, and to maintain randomization, we propose an alternative design that allows participants' preference after randomization, which we call a "preference option randomized design (PORD)". In contrast to other preference designs, which ask whether or not participants consent to the assigned intervention after randomization, the crucial feature of preference option randomized design is its unique informed consent process before randomization. Specifically, the preference option randomized design consent process informs participants that they can opt out and switch to the other intervention only if after randomization they actively express the desire to do so. Participants who do not independently express explicit alternate preference or assent to the randomly assigned intervention are considered to not have an alternate preference. In sum, preference option randomized design intends to maximize retention, minimize possibility of forced assignment for any participants, and to maintain randomization by allowing participants with no or equal preference to represent random assignments. This design scheme enables to define five effects that are interconnected with each other through common design parameters-comparative, preference, selection, intent-to-treat, and overall/as-treated-to collectively guide decision making between interventions. Statistical power functions for testing all these effects are derived, and simulations verified the validity of the power functions under normal and binomial distributions.

Keywords: Preference; comparative effectiveness research; decision making; power; randomization.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Illustration diagram of preference option randomized design.
Figure 2.
Figure 2.
Comparisons of statistical power across five effects with varying stay-in rates πS=P(AS|RA)=P(BS|RS) under a special case of: n(RA)=n(RB)=n(R)=300, E(Y|AS)=0.9, E(Y|BS)=0.4, E(Y|AB)=1.2, E(Y|BA) 0.6, and σ2=1. A: theoretical statistical power: B: empirical statistical power based on 10,000 simulations. Black and gray lines represent theoretical and empirical power, respectively.

Similar articles

Cited by

References

    1. Westfall JM, Mold J and Fagnan L. Practice-based research – “Blue Highways” on the NIH roadmap. JAMA 2007; 297: 403–406. - PubMed
    1. Waldman SA and Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci 2010; 3: 254–257. - PMC - PubMed
    1. Concato J, Peduzzi P, Huang GD, et al. Comparative effectiveness research: what kind of studies do we need? J Investig Med 2010; 58: 764–769. - PubMed
    1. Corbett MS, Watson J and Eastwood A. Randomised trials comparing different healthcare settings: an exploratory review of the impact of pre-trial preferences on participation, and discussion of other methodological challenges. BMC Health Serv Res 2016; 16: 8. - PMC - PubMed
    1. Sidani S, Fox M, Streiner DL, et al. Examining the influence of treatment preferences on attrition, adherence and outcomes: a protocol for a two-stage partially randomized trial. BMC Nurs 2015; 14: 57. - PMC - PubMed

Publication types

MeSH terms